| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |